Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aloys SL Tijsma"'
Autor:
Hanmi Noh, Jong-In Kim, Ji-Min Seo, Manki Song, Minho Lee, Sang-Seok Oh, Hyo-Young Chung, Sun-Je Woo, Carel A. van Baalen, Eunji Yang, Soo Young Lee, Dong Kyun Ryu, Patricia M. Nuijten, Ki-Sung Kwon, Su-Kyeong Eo, Bobin Kang, Minsoo Kim, Gippeum Lim, Seong-Gyu Kim, Jung-ah Choi, Aloys Sl. Tijsma, Cheol-Min Kim
Publikováno v:
Biochemical and Biophysical Research Communications
The SARS-CoV-2 variant is rapidly spreading across the world and causes to resurge infections. We previously reported that CT-P59 presented its in vivo potency against Beta variants, despite its reduced activity in cell experiments. Yet, it remains u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8945a7c6c7cd1874f874091332241ce9
https://doi.org/10.1016/j.bbrc.2021.09.023
https://doi.org/10.1016/j.bbrc.2021.09.023
BackgroundNitazoxanide (NTZ) is a broad-spectrum antiviral undergoing clinical development for treating influenza and other viral respiratory infections such as those caused by rhinovirus/enterovirus and coronavirus including the emerging SARS-CoV-2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e662258c034933e83d797cc69993db09
https://doi.org/10.1101/2021.07.30.454324
https://doi.org/10.1101/2021.07.30.454324
Autor:
Dong-Kyun Ryu, Bobin Kang, Sun-Je Woo, Min-Ho Lee, Aloys SL Tijsma, Hanmi Noh, Jong-In Kim, Ji-Min Seo, Cheolmin Kim, Minsoo Kim, Eunji Yang, Gippeum Lim, Seong-Gyu Kim, Su-Kyeong Eo, Jung-ah Choi, Sang-Seok Oh, Patricia M Nuijten, Manki Song, Hyo-Young Chung, Carel A van Baalen, Ki-Sung Kwon, Soo-Young Lee
P.1. or gamma variant also known as the Brazil variant, is one of the variants of concern (VOC) which appears to have high transmissibility and mortality. To explore the potency of the CT-P59 monoclonal antibody against P.1 variant, we tried to condu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebf44020d949e07f94abe9973e0785ff
https://doi.org/10.1101/2021.07.08.451696
https://doi.org/10.1101/2021.07.08.451696
Autor:
Tandile Hermanus, Ki-Sung Kwon, rina song, Minsoo Kim, Prudence Kgagudi, Jong-In Kim, Carel A. van Baalen, Young-Il Kim, Cheol-Min Kim, Patricia M. Nuijten, Young Ki Choi, Penny L. Moore, Dong Kyun Ryu, Aloys Sl. Tijsma, Soo Young Lee, Thandeka Moyo-Gwete
Publikováno v:
Biochemical and Biophysical Research Communications
The global circulation of newly emerging variants of SARS-CoV-2 is a new threat to public health due to their increased transmissibility and immune evasion. Moreover, currently available vaccines and therapeutic antibodies were shown to be less effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::760fdc72211cdd4621b8f53c21ea1de6
https://doi.org/10.1101/2021.04.27.441707
https://doi.org/10.1101/2021.04.27.441707